NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed ...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed ...
Source: pr-inside.com
Viricides Platform Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Viricides Platform Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Viricides Platform Technology Today - Breaking & Trending Today
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock
SHELTON, CT / ACCESSWIRE / April 30, 2024 / NanoViricides, Inc. (NYSE Amer:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that the Phase I Clinical Trial of NV-387 is completed successfully and data lock is expected soon.The Phase 1 clinical trial, protocol number...
Source: pharmiweb.com
NanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial Healthy Subjects Part Successfu
SHELTON, CT / ACCESSWIRE / February 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that it has filed its Quarterly Report on Form 10-Q for the fiscal second quarter ending December 31, 2023 with the Securities and Exch...
Source: pharmiweb.com
NanoViricides Has Filed its Quarterly Report - NV-387 Broad-Spectrum ...
NanoViricides Has Filed its Quarterly Report - NV-387 Broad-Spectrum ...
Source: pr-inside.com